日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival and Treatment Patterns in Stage III Inflammatory and Noninflammatory Breast Cancer

III期炎性乳腺癌和非炎性乳腺癌的生存和治疗模式

Leone, José P; Leone, Julieta; De Placido, Pietro; Nakhlis, Faina; Schlam, Ilana; Hirko, Kelly A; Hazra, Aditi; Troll, Elizabeth; Bellon, Jennifer R; Vallejo, Carlos T; Lin, Nancy U; Tolaney, Sara M; Lynce, Filipa

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer

新辅助帕博利珠单抗联合化疗治疗非转移性三阴性炎性乳腺癌,达到病理完全缓解

Lynce, F; Valenza, C; Niman, S M; Bertucci, F; Kai, M; Ryan, S; Troll, E; Layman, R M; Fanucci, K A; Giordano, A; Nasrazadani, A; Nakhlis, F; Bellon, J; Warren, L; Block, C; Schumer, S; Lucci, A; Krishnamurthy, S; Trapani, D; Lerebours, F; Dalenc, F; Levy, C; Petit, T; Leheurteur, M; Bachelot, T; Tredan, O; Ribeiro, J M; Pistilli, B; Zagami, P; Ladoire, S; Lopez Almeida, L; Zemmour, C; Carey, L A; Tolaney, S M; Valero, V; Curigliano, G; Regan, M M; Goncalves, A; Woodward, W A

Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice

美国常规临床实践中,CDK4/6抑制剂联合芳香化酶抑制剂治疗HR+/HER2-转移性乳腺癌患者的真实世界无进展生存期2(PFS2)和肿瘤反应

Rugo, Hope S; Brufsky, Adam; Layman, Rachel M; Liu, Xianchen; Li, Benjamin; McRoy, Lynn; Cohen, Aaron B; Estevez, Melissa; Lynce, Filipa; Cottu, Paul; Thill, Marc; Curigliano, Giuseppe

Beyond Neutropenic Fever: Severe Multiorgan Immune-Related Toxicity Induced by Pembrolizumab

中性粒细胞减少性发热之外:帕博利珠单抗诱发的严重多器官免疫相关毒性

Anastácio, Marta; Pina Cabral, Tiago; Roldão, Marta; Salgadinho Machado, Andreia; Lynce, Ana

Primary Extracranial Ewing Sarcoma Complicated by Hemorrhagic Shock and Multimicrobial Infection: A Diagnostic and Therapeutic Challenge

原发性颅外尤文氏肉瘤并发出血性休克和多重微生物感染:诊断和治疗的挑战

Anastácio, Marta; Roldão, Marta; Salgadinho Machado, Andreia; Maia, Daniela; Lynce, Ana

Implantation of engineered adipocytes suppresses tumor progression in cancer models.

植入工程化脂肪细胞可抑制癌症模型中的肿瘤进展

Nguyen Hai P, An Kelly, Ito Yusuke, Kharbikar Bhushan N, Sheng Rory, Paredes Breanna, Murray Elizabeth, Pham Kimberly, Bruck Michael, Zhou Xujia, Biellak Cassandra, Ushiki Aki, Nobuhara Mai, Fong Sarah L, Bernards Daniel A, Lynce Filipa, Dillon Deborah A, Magbanua Mark Jesus M, Huppert Laura A, Hammerlindl Heinz, Klein Jace Anton, Valdiviez Luis, Fiehn Oliver, Esserman Laura, Desai Tejal A, Yee Sook Wah, Rosenbluth Jennifer M, Ahituv Nadav

Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy

血清分析物作为预测三阴性乳腺癌患者疾病复发和无侵袭性疾病生存期的指标,这些患者均参与了 OXEL 试验,接受了免疫疗法、化疗或化疗联合免疫疗法治疗。

Toney, Nicole J; Lynch, Megan T; Lynce, Filipa; Mainor, Candace; Isaacs, Claudine; Schlom, Jeffrey; Donahue, Renee N

Clinicogenomic Characterization of Inflammatory Breast Cancer

炎性乳腺癌的临床基因组学特征分析

Priedigkeit, Nolan; Harrison, Beth; Shue, Robert; Hughes, Melissa E; Li, Yvonne; Lebrón-Torres, Alinés; Kirkner, Gregory J; Spurr, Liam F; Remolano, Marie Claire; Strauss, Sarah; Files, Janet; Feeney, Anne-Marie; Grant, Libby; Mohammed-Abreu, Ayesha; Garrido-Castro, Ana; Barroso-Sousa, Romualdo; Bychkovsky, Brittany; Nakhlis, Faina; Bellon, Jennifer R; King, Tari A; Winer, Eric P; Lindeman, Neal; Johnson, Bruce E; Sholl, Lynette; Dillon, Deborah; Overmoyer, Beth; Tolaney, Sara M; Cherniack, Andrew D; Lin, Nancy U; Lynce, Filipa

Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting

在美国真实世界环境中,CDK4/6抑制剂联合芳香化酶抑制剂治疗HR+/HER2-转移性乳腺癌患者的总生存期比较

Rugo, H S; Layman, R M; Lynce, F; Liu, X; Li, B; McRoy, L; Cohen, A B; Estevez, M; Curigliano, G; Brufsky, A

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers

HER2阳性炎性乳腺癌中的HER2DX:相关性分析及与非炎性乳腺癌的比较分析

Lynce, F; Martínez-Sáez, O; Walbaum, B; Brasó-Maristany, F; Waks, A G; Villagrasa, P; Villacampa Javierre, G; Sanfeliu, E; Galván, P; Paré, L; Anderson, L M; Perou, C M; Parker, J S; Vivancos, A; DiLullo, M K; Pernas, S; Winer, E P; Overmoyer, B; Mittendorf, E A; Bueno-Muiño, C; Martín, M; Prat, A; Tolaney, S M